Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mack Roach

Showing results (261-270 of 284) with videos related to

Pageof 29
Sort By:
JCO Clinical Cancer Informatics|May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III TrialsMack Roach, Jingbin Zhang, Osama Mohamad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2020
Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-AnalysisDaniel E Spratt, Shawn Malone, Soumyajit Roy, et al.
European Urology Oncology|July 19, 2025
Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate CancerSoumyajit Roy, Yilun Sun, James A Eastham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 17, 2013
Prostate cancer, version 1.2014James L Mohler, Philip W Kantoff, Andrew J Armstrong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2012
Prostate cancer, Version 3.2012: featured updates to the NCCN guidelinesJames L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.
NPJ Digital Medicine|June 8, 2022
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
NPJ Digital Medicine|February 22, 2023
Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2025
Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor RecurrenceAnson T Ku, Uma Shankavaram, Shana Y Trostel, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2020
Understanding High-Dose, Ultra-High Dose Rate, and Spatially Fractionated Radiation TherapyRobert J Griffin, Mansoor M Ahmed, Beatriz Amendola, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 5, 2021
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021Edward Schaeffer, Sandy Srinivas, Emmanuel S Antonarakis, et al.
Pageof 29

Showing results (261-270 of 284) with videos related to

Sort By:
Pageof 29
JCO Clinical Cancer Informatics|May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III TrialsMack Roach, Jingbin Zhang, Osama Mohamad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2020
Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-AnalysisDaniel E Spratt, Shawn Malone, Soumyajit Roy, et al.
European Urology Oncology|July 19, 2025
Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate CancerSoumyajit Roy, Yilun Sun, James A Eastham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 17, 2013
Prostate cancer, version 1.2014James L Mohler, Philip W Kantoff, Andrew J Armstrong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2012
Prostate cancer, Version 3.2012: featured updates to the NCCN guidelinesJames L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.
NPJ Digital Medicine|June 8, 2022
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
NPJ Digital Medicine|February 22, 2023
Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2025
Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor RecurrenceAnson T Ku, Uma Shankavaram, Shana Y Trostel, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2020
Understanding High-Dose, Ultra-High Dose Rate, and Spatially Fractionated Radiation TherapyRobert J Griffin, Mansoor M Ahmed, Beatriz Amendola, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 5, 2021
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021Edward Schaeffer, Sandy Srinivas, Emmanuel S Antonarakis, et al.
Pageof 29